Arcataur Capital Management »

Aquestive Therapeutics shares owned by Arcataur Capital Management

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Arcataur Capital Management from 13F filings

Historical chart of Arcataur Capital Management investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by Arcataur Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by Arcataur Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $239k 37k 6.46

More positions owned by Arcataur Capital Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Msci Eafe Etf (EFA)
Vanguard Whitehall Fds High Div Yld (VYM)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Vanguard Bd Index Fds Intermed Term (BIV)

View all positions for Arcataur Capital Management

Top funds holding Aquestive Therapeutics

Bratton Capital Management
BlackRock
Rtw Investments
Vanguard Group
Perceptive Advisors
EcoR1 Capital
Samsara BioCapital
State Street Corporation
Geode Capital Management
Federated Investors
Sio Capital Management
Millennium Management
Susquehanna International
Wells Fargo & Company
Bnp Paribas Arbitrage, Snc

View all funds holding Aquestive Therapeutics